Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner O F, Ulm M, Streli C, Ludvik B
Department of Medicine III, University of Vienna, Austria.
Diabetes Care. 1997 Nov;20(11):1717-23. doi: 10.2337/diacare.20.11.1717.
To evaluate beta-cell secretion and glucose metabolism in lean subjects with gestational diabetes mellitus (GDM) compared with that in subjects with normal pregnancy and obesity.
Insulin secretion, insulin sensitivity (S1), and hepatic insulin extraction were assessed in pregnant women with GDM before and after delivery and in those with normal glucose tolerance (NGT) in comparison to healthy nonpregnant lean and obese women. Kinetic analysis of glucose, insulin, and C-peptide plasma concentrations during oral and intravenous glucose tolerance tests was performed by mathematical modeling.
S1 was blunted in pregnant women with GDM by 84% and in those with NGT by 66% compared with lean nonpregnant women (P < 0.005 vs. healthy nonpregnant lean control subjects; P < 0.05, GDM vs. pregnant women with NGT), whereas glucose effectiveness was decreased by 33% in both pregnant groups (P < 0.05 vs. healthy nonpregnant lean control subjects). Insulin secretion was 30% higher (P < 0.05) in subjects with GDM than in pregnant women with NGT or in nonpregnant lean women, but decreased (P < 0.005) when compared with obese women with a comparable degree of insulin resistance. Fractional hepatic insulin extraction was similar in both pregnant groups, being lower (P < 0.0001) by 30% versus nonpregnant females. beta-cell sensitivity to glucose for insulin release was decreased in subjects with GDM versus pregnant women with NGT as well as nonpregnant women by 40-50% (P < 0.01). Twelve weeks after delivery, GDM returned to normal glucose tolerance, but S1 remained 50% lower than that in lean nonpregnant women, while beta-cell sensitivity to glucose did not change (P < 0.01 vs. healthy nonpregnant lean control subjects).
Pregnancy is characterized by insulin resistance, diminished hepatic insulin extraction, and glucose effectiveness. Lean subjects with GDM are additionally characterized by having more pronounced insulin resistance and inadequate insulin secretion, which persist after delivery. Compared with other insulin-resistant prediabetic states like impaired glucose tolerance (IGT), defective insulin secretion seems to be a predominant defect in lean GDM subjects, indicating that it might represent a specific prediabetic condition.
评估与正常妊娠及肥胖受试者相比,妊娠糖尿病(GDM)的瘦型受试者的β细胞分泌及葡萄糖代谢情况。
对GDM孕妇分娩前后以及葡萄糖耐量正常(NGT)的孕妇进行胰岛素分泌、胰岛素敏感性(S1)及肝脏胰岛素摄取的评估,并与健康非妊娠瘦型及肥胖女性进行比较。通过数学建模对口服及静脉葡萄糖耐量试验期间的葡萄糖、胰岛素及C肽血浆浓度进行动力学分析。
与非妊娠瘦型女性相比,GDM孕妇的S1降低了84%,NGT孕妇的S1降低了66%(与健康非妊娠瘦型对照受试者相比,P<0.005;GDM与NGT孕妇相比,P<0.05),而两组妊娠组的葡萄糖效能均降低了33%(与健康非妊娠瘦型对照受试者相比,P<0.05)。GDM受试者的胰岛素分泌比NGT孕妇或非妊娠瘦型女性高30%(P<0.05),但与胰岛素抵抗程度相当的肥胖女性相比则降低了(P<0.005)。两组妊娠组的肝脏胰岛素摄取分数相似,与非妊娠女性相比降低了30%(P<0.0001)。与NGT孕妇及非妊娠女性相比,GDM受试者的β细胞对葡萄糖刺激的胰岛素释放敏感性降低了40%-50%(P<0.01)。分娩后12周,GDM恢复至正常葡萄糖耐量,但S1仍比非妊娠瘦型女性低50%,而β细胞对葡萄糖的敏感性未发生变化(与健康非妊娠瘦型对照受试者相比,P<0.01)。
妊娠的特征为胰岛素抵抗、肝脏胰岛素摄取减少及葡萄糖效能降低。GDM的瘦型受试者还具有更明显的胰岛素抵抗及胰岛素分泌不足的特点,且这些特点在分娩后持续存在。与其他胰岛素抵抗的糖尿病前期状态如糖耐量受损(IGT)相比,胰岛素分泌缺陷似乎是GDM瘦型受试者的主要缺陷,这表明其可能代表一种特殊的糖尿病前期状态。